TY - JOUR
T1 - Congenital Trypanosoma cruzi Transmission in Santa Cruz, Bolivia
AU - Bern, Caryn
AU - Verastegui, Manuela
AU - Gilman, Robert H.
AU - LaFuente, Carlos
AU - Galdos-Cardenas, Gerson
AU - Calderon, Maritza
AU - Pacori, Juan
AU - Del Carmen Abastoflor, Maria
AU - Aparicio, Hugo
AU - Brady, Mark F.
AU - Ferrufino, Lisbeth
AU - Angulo, Noelia
AU - Marcus, Sarah
AU - Sterling, Charles
AU - Maguire, James H.
N1 - Funding Information:
We are grateful to Henry Bishop and Michael Arrowood for reviewing the umbilical tissue slides and for providing slide images. Financial support. National Institutes of Health (NIH; 1R21 AI072093–01, NIH Fogarty Scholars Program R24TW007988, NIH Training Grant in Infectious and Tropical Diseases #5 T35 AI065385, and NIH Global Research Training Grant D43 TW006581) and a private Swiss foundation. Potential conflicts of interest. All authors: no conflicts.
PY - 2009/12
Y1 - 2009/12
N2 - Background: We conducted a study of congenital Trypanosoma cruzi infection in Santa Cruz, Bolivia. Our objective was to apply new tools to identify weak points in current screening algorithms, and find ways to improve them. Methods: Women presenting for delivery were screened by rapid and conventional serological tests. For infants of infected mothers, blood specimens obtained on days 0, 7, 21, 30, 90, 180, and 270 were concentrated and examined microscopically; serological tests were performed for the day 90, 180, and 270 specimens. Maternal and infant specimens, including umbilical tissue, were tested by polymerase chain reaction (PCR) targeting the kinetoplast minicircle and by quantitative PCR. Results: Of 530 women, 154 (29%) were seropositive. Ten infants had congenital T. cruzi infection. Only 4 infants had positive results of microscopy evaluation in the first month, and none had positive cord blood microscopy results. PCR results were positive for 6 (67%) of 9 cord blood and 7 (87.5%) of 8 umbilical tissue specimens. PCR-positive women were more likely to transmit T. cruzi than were seropositive women with negative PCR results (P<.05). Parasite loads determined by quantitative PCR were higher for mothers of infected infants than for seropositive mothers of uninfected infants (P <.01). Despite intensive efforts, only 58% of at-risk infants had a month 9 specimen collected. Conclusions: On the basis of the low sensitivity of microscopy in cord blood and high rate of loss to followup, we estimate that current screening programs miss one-half of all infected infants. Molecular techniques may improve early detection.
AB - Background: We conducted a study of congenital Trypanosoma cruzi infection in Santa Cruz, Bolivia. Our objective was to apply new tools to identify weak points in current screening algorithms, and find ways to improve them. Methods: Women presenting for delivery were screened by rapid and conventional serological tests. For infants of infected mothers, blood specimens obtained on days 0, 7, 21, 30, 90, 180, and 270 were concentrated and examined microscopically; serological tests were performed for the day 90, 180, and 270 specimens. Maternal and infant specimens, including umbilical tissue, were tested by polymerase chain reaction (PCR) targeting the kinetoplast minicircle and by quantitative PCR. Results: Of 530 women, 154 (29%) were seropositive. Ten infants had congenital T. cruzi infection. Only 4 infants had positive results of microscopy evaluation in the first month, and none had positive cord blood microscopy results. PCR results were positive for 6 (67%) of 9 cord blood and 7 (87.5%) of 8 umbilical tissue specimens. PCR-positive women were more likely to transmit T. cruzi than were seropositive women with negative PCR results (P<.05). Parasite loads determined by quantitative PCR were higher for mothers of infected infants than for seropositive mothers of uninfected infants (P <.01). Despite intensive efforts, only 58% of at-risk infants had a month 9 specimen collected. Conclusions: On the basis of the low sensitivity of microscopy in cord blood and high rate of loss to followup, we estimate that current screening programs miss one-half of all infected infants. Molecular techniques may improve early detection.
UR - http://www.scopus.com/inward/record.url?scp=72849147217&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=72849147217&partnerID=8YFLogxK
U2 - 10.1086/648070
DO - 10.1086/648070
M3 - Article
C2 - 19877966
AN - SCOPUS:72849147217
SN - 1058-4838
VL - 49
SP - 1667
EP - 1674
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 11
ER -